This mirrors a recent experimental finding that reports an association between the failure to respond to tamoxifen treatment and the expression patterns of genes involved in cholesterol and fatty acid metabolism for estrogen receptor positive (ER+) breast tumours [17]. The gene discussed is ESR1; the disease is breast neoplasm.